Jpmorgan Chase & CO Prokidney Corp Ord Shs Cl A(Cy Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Jpmorgan Chase & CO holds 46,830 shares of PROK stock, worth $83,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,830
Previous 28,358
65.14%
Holding current value
$83,357
Previous $69,000
28.99%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PROK
# of Institutions
77Shares Held
46.2MCall Options Held
505KPut Options Held
127K-
Morgan Stanley New York, NY14.3MShares$25.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$22 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.22MShares$9.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$6.51 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.92 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $110M